Related Experiment Videos
[The lipoproteins in human diabetic cataract]
1Department of Ophthalmology, Koshigaya Hospital, Dokkyo University School of Medicine, Saitama-ken, Japan.
Nippon Ganka Gakkai Zasshi
|May 1, 1994
Summary
Diabetic cataract lenses show increased levels of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) compared to senile cataracts. Total lipoprotein levels remained similar between the two groups.
Area of Science:
- Ophthalmology
- Biochemistry
- Cell Biology
Context:
- Diabetic cataracts are a significant complication of diabetes mellitus.
- Lipoprotein metabolism plays a role in lens health.
- Understanding molecular changes in diabetic cataracts is crucial for developing targeted therapies.
Purpose:
- To quantify and compare lipoprotein fractions in human diabetic and senile cataract lenses.
- To investigate the localization of low density lipoprotein (LDL) receptors in cataractous lenses.
Summary:
- Lipoprotein fractions including chylomicrons, very low density lipoproteins (VLDL), low density lipoproteins (LDL), and high density lipoproteins (HDL) were isolated and quantified from human diabetic and senile cataract lenses.
- While total lipoprotein content did not differ significantly, diabetic cataracts exhibited significantly higher concentrations of VLDL and LDL compared to senile cataracts.
- Histological analysis confirmed the presence of LDL receptors on the lens epithelium and underlying layers.
Impact:
- This study reveals specific alterations in lipoprotein composition within diabetic cataracts, highlighting VLDL and LDL accumulation.
- The findings suggest a potential role for altered lipoprotein metabolism and LDL receptor activity in the pathogenesis of diabetic cataracts.
- These insights could inform future research into diagnostic markers and therapeutic strategies for diabetic eye complications.